Ra Capital sells $10.17 million of Vor Biopharma common stock By Investing.com

robot
Abstract generation in progress

RA Capital Healthcare Fund LP sold 630,374 shares of Vor Biopharma Inc. (NASDAQ:VOR) common stock for approximately $10.17 million across two transactions in April 2026. Following these sales, RA Capital Healthcare Fund LP retains 2,567,245 shares of Vor Biopharma. The company has recently shifted its focus to autoimmune therapies and initiated a global Phase 3 trial for Sjögren’s disease, while analysts have adjusted price targets but largely maintain positive ratings due to promising drug potential.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin